FDA Approves Merck’s Winrevair for Pulmonary Arterial Hypertension
The U.S. Food and Drug Administration (FDA) recently approved Winrevair, a new treatment developed by pharmaceutical [...]
Study Links GLP-1 Diabetes and Obesity Drugs to Increased Risk of Aspiration Pneumonia Post-Endoscopy
A recent study highlighted in the journal Gastroenterology has unveiled potential concerns associated with GLP-1 diabetes [...]
Breakthrough Study Identifies Three Subtypes of Multiple Sclerosis Based on Immune Markers
A groundbreaking study conducted in Germany has unveiled three distinct subtypes of Multiple Sclerosis (MS), categorized [...]
Bristol Myers Squibb Announces Layoffs at Mirati Therapeutics Following Acquisition
Bristol Myers Squibb (BMS) has initiated a significant workforce reduction at the headquarters of the recently [...]
Switzerland’s Progressive Approach to Opioid Addiction Treatment: A Model for Success
In Zurich, Switzerland, the Arud Centre for Addiction Medicine offers a pioneering approach to opioid addiction, [...]
MilliporeSigma Announces Major Investment in South Korean Bioprocessing Plant
MilliporeSigma, the life science division of Merck KGaA, has committed to a significant expansion in Asia-Pacific [...]
Lenz Therapeutics Opts for Reverse Merger Ahead of Phase 3 Results
Lenz Therapeutics made its Nasdaq debut through a reverse merger, a strategic choice that CEO Eef [...]
Nvidia Unveils AI Microservices for Healthcare Innovation at GTC Conference
At its annual GTC conference, Nvidia introduced 25 generative AI microservices aimed at revolutionizing the healthcare [...]
Texas Medical Board Proposes Guidance on Legal Abortion in Medical Emergencies
The Texas Medical Board has released draft guidance aimed at clarifying when abortions are legally permissible [...]
Job Cuts at Bellus Health Following GSK’s $2 Billion Acquisition
In the wake of GSK's $2 billion acquisition of Bellus Health, an undisclosed number of Bellus [...]
Expanded Coverage for Anti-Obesity Drugs in U.S. Government Health Programs
The Centers for Medicare and Medicaid Services (CMS) has issued guidance for Medicare Part D plans [...]
U.S. Drug Overdose Deaths Hit Record High in 2022, Showing Signs of Stabilizing Crisis
The U.S. saw a record 107,941 drug overdose deaths in 2022, a slight rise from the [...]
The Evolution and Future of CAR-T Cell Therapies: Overcoming Manufacturing Hurdles for Cancer Treatment
In the summer of 2017, Novartis took a significant step in cancer treatment with the approval [...]
EPA’s Asbestos Ban: A Major Step Forward with Long-Term Public Health Implications
The Environmental Protection Agency (EPA) has announced a comprehensive ban on all forms of asbestos in [...]
AstraZeneca Acquires Fusion Pharmaceuticals for $2 Billion
AstraZeneca has announced a $2 billion acquisition of Fusion Pharmaceuticals, significantly investing in the burgeoning field [...]
UnitedHealth Advances $2 Billion to Providers After Cyberattack on Change Healthcare
UnitedHealth Group has distributed over $2 billion in advance payments to healthcare providers impacted by a [...]
EU Spearheads Real-World Evidence Projects to Revolutionize Healthcare Decision-Making
The European Union is in charge of integrating real-world evidence (RWE) and advanced data analytics into [...]
Zephyr AI Secures $111M in Series A Funding to Revolutionize Healthcare with AI
Zephyr AI, a US-based healthcare technology company, has successfully raised $111 million in a Series A [...]
FDA Outlines Regulatory Framework for AI in Medical Products
The FDA has published a comprehensive plan to regulate artificial intelligence (AI) in medical products, marking [...]
The Experimental Quest for Longevity: Rapamycin’s Rising Popularity
At 77, David Sandler from Bergen County, N.J., has ventured into an experimental approach to longevity [...]
AstraZeneca Boosts Rare Diseases Portfolio with Acquisition of Amolyt Pharma
AstraZeneca has announced a definitive plan on Thursday, March 14 to acquire Amolyt Pharma, a clinical-stage [...]
FDA Approves First Drug for Fatty Liver Disease by Madrigal Pharmaceuticals
The FDA has approved Madrigal Pharmaceuticals' Rezdiffra, the first treatment for metabolic dysfunction-associated steatohepatitis (MASH), offering [...]
Amazon and Eli Lilly Partner for Telehealth Medication Delivery Amid Drug Shortages
Amazon has partnered with Eli Lilly to distribute select medications, including GLP-1 drugs Mounjaro and Zepbound, [...]
President Biden’s State of the Union: A Focus on Healthcare, Drug Pricing, and Reproductive Rights Amid Election Season
In his State of the Union address, President Joe Biden highlighted healthcare as a central priority, [...]
Biden Administration Proposes Increased FDA Funding for FY 2025 to Enhance Innovation and Health Services
Just days after the FDA’s fiscal year 2024 appropriations package was passed, the Biden administration is [...]